logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Manufacturers
    3. LEO Pharma Inc.

    LEO Pharma Inc. drugs

    FiltersReset Filters
    5 results

    • adbry

      (tralokinumab-ldrm)
      Medication Details
      LEO Pharma Inc.
      Usage: ADBRY is indicated for treating moderate-to-severe atopic dermatitis in adults and pediatric patients aged 12 and older when topical therapies are insufficient or inappropriate. It can be used alone or in conjunction with topical corticosteroids.
      Medication Details
      Drug Interactions

    • enstilar

      (calcipotriene and betamethasone dipropionate)
      Medication Details
      LEO Pharma Inc.
      Usage: Enstilar® Foam is indicated for the topical treatment of plaque psoriasis in patients aged 12 years and older.
      Medication Details
      Drug Interactions

    • finacea

      (azelaic acid)
      Medication Details
      LEO Pharma Inc.
      Usage: FINACEA Gel, 15% is indicated for the topical treatment of inflammatory papules and pustules in mild to moderate rosacea. It is not evaluated for treating erythema without papules and pustules.
      Medication Details
      Drug Interactions

    • finacea foam - azelaic acid aerosol, foam

      (Azelaic Acid)
      Medication Details
      Leo Pharma Inc.
      Medication Details

    • spevigo

      (Spesolimab)
      Medication Details
      Leo Pharma Inc.
      Medication Details
      Drug Interactions